Table 1.
Comparisons of hypoglycemic drugs used in two groups of patients.
| Hypoglycemic drugs | Study group (n=47) | Control group (n=38) | P value |
|---|---|---|---|
| Metformin, n (%) | 30 (63.80%) | 21 (55.30%) | 0.506 |
| Acarbose, n (%) | 16 (34.00%) | 7 (18.40%) | 0.142 |
| Insulin secretagogues, n (%) | 4 (8.50%) | 2 (5.30%) | 0.687 |
| SGLT-2 inhibitors, n (%) | 7 (14.90%) | 10 (26.30%) | 0.276 |
| Insulin sensitizer, n (%) | 2 (4.30%) | 1 (2.60%) | >0.999 |
| Insulin, n (%) | 8 (17.00%) | 4 (10.50%) | 0.535 |
| Liraglutide, n (%) | |||
| 0.6 mg | 2 (4.30%) | ||
| 1.2 mg | 16 (34.00%) | ||
| 1.8 mg | 29 (61.70%) |
SGLT, Sodium-dependent glucose cotransporters.